Stefani Wolff Insider Trading $PRNB Principia Biopharma Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stefani Wolff.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Stefani Wolff. Stefani Wolff is Chief Development Officer in Principia Biopharma Inc. ($PRNB) and Director in Rain Therapeutics Inc. ($RAIN).
Stefani Wolff in Principia Biopharma Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Stefani Wolff: Chief Development Officer
Holdings: 13,592 shares
Latest Transaction: Sep 28 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Stefani Wolff in Principia Biopharma Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 67.31 | 55,000 | 3,702,050 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 35.42 | 60,000 | 2,125,200 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 17.00 | 55,042 | 935,714 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 11.35 | 22,017 | 250,001 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 7.27 | 16,843 | 122,400 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | D | 4.54 | 30,056 | 136,514 | 0 | |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | U | 100.00 | 13,592 | 1,359,200 | 0 | 13.6 K to 0 (-100.00 %) |
| Sep 28 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Gift | G | 0.00 | 5,504 | 0 | 13,592 | 19.1 K to 13.6 K (-28.82 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 61.37 | 100 | 6,137 | 19,096 | 19.2 K to 19.1 K (-0.52 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 61.37 | 100 | 6,137 | 19,096 | 19.2 K to 19.1 K (-0.52 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 60.81 | 5,004 | 304,291 | 19,196 | 24.2 K to 19.2 K (-20.68 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 60.81 | 5,004 | 304,291 | 19,196 | 24.2 K to 19.2 K (-20.68 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 59.89 | 400 | 23,957 | 24,200 | 24.6 K to 24.2 K (-1.63 %) |
| Jun 17 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 59.89 | 400 | 23,957 | 24,200 | 24.6 K to 24.2 K (-1.63 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | M | 4.54 | 5,504 | 24,999 | 19,047 | |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 46.36 | 3,750 | 173,838 | 35,609 | 39.4 K to 35.6 K (-9.53 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 45.72 | 1,754 | 80,192 | 39,359 | 41.1 K to 39.4 K (-4.27 %) |
| Mar 18 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Buy | M | 4.54 | 5,504 | 24,999 | 41,113 | 35.6 K to 41.1 K (+15.46 %) |
| Mar 05 2020 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | A | 67.31 | 55,000 | 3,702,050 | 55,000 | |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | M | 4.54 | 5,505 | 25,004 | 24,551 | |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 49.87 | 1,300 | 64,825 | 35,609 | 36.9 K to 35.6 K (-3.52 %) |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Sell | S | 49.29 | 4,205 | 207,266 | 36,909 | 41.1 K to 36.9 K (-10.23 %) |
| Dec 18 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Buy | M | 4.54 | 5,505 | 25,004 | 41,114 | 35.6 K to 41.1 K (+15.46 %) |
| Mar 08 2019 | PRNB | Principia Biopharm ... | Wolff Stefani | Chief Development O ... | Option Exercise | A | 35.42 | 60,000 | 2,125,200 | 60,000 |
Page: 1